CellVax is featured in the newspaper "Folha de São Paulo", Brazil.
- CellVax Therapeutics
- Feb 18
- 1 min read
Fernando Kreutz, CEO of CellVax, details how the vaccine developed, already being tested in the United States, improves the treatment of prostate cancer, prevents recurrence and could revolutionize the treatment of the disease.
Click to access. https://www1.folha.uol.com.br/